Home' Australian Pharmacist : Australian Pharmacist December 2015 Contents Australian Pharmacist December 2015 I © Pharmaceutical Society of Australia Ltd.
Items in the Product news section are prepared from information provided by the companies named in each
item. They are included for the information of PSA members. It is up to the individual member to use their
professional judgment to decide on the merit or otherwise of each product mentioned. PSA neither endorses
nor confirms claims made in the items. (Where provided by the company references citing evidence are
included with the items.)
Australian Pharmacist is a professional journal. It will carry only advertising which is likely to be of interest to all
pharmacists and which does not reflect unfavourably directly or by implication on the pharmacy profession or
the professional practice of pharmacy. Advertising which does not comply with this policy will be refused. It is
the responsibility of the advertisers to comply with the relevant Commonwealth and State law. Advertising does
not constitute an endorsement by PSA of the claims, products or services.
Read in greater detail more regularly than any other pharmacy title –
such constant behaviour means you can count on our readers to open
any issue and be seen!
» Greatest number of recipients opening and reading (82%)
» Greatest number of readers reading every issue (48%)
Engage with almost 18,800 PSA members every month
(15,500 pharmacists in print and 16,000 in digital form).
» Australian Pharmacist is read by 65% of community pharmacists
It has an extremely strong CPD program followed by more than
10,000 pharmacists – a typical monthly article receives 3000 plus
assessments, with highs over 4000!
» Greatest average proportion read (73%)
» Circulation 14,872 cab March 2013
TO ADVERTISE in the best-read pages in pharmacy media and give your campaign real
impact, and greater recognition, contact Tremain Media.
Ph: 02 9988 4689
Ph: 02 9871 5520
Ph: 0402 055 022
*Competitive Advantage Research August 2012 – 632 practicing community pharmacists
Answers for crossword on page 71.
Across: 1. Nausea, 9. Immunocompetent,
12. Lesion, 13. Impetigo, 14. Vesicle,
Down: 2. Swollen, 3. Hygiene,
4. Dormant, 5. Ulcer, 6. Blister, 7. Lymph,
8. Famciclovir, 10. Cheilitis, 11. Fever.
Key Pharmaceuticals has launched
Ostevit-D one-a -week to facilitate
adherence to Vitamin D therapy for
Australian consumers. Vitamin D is
an important fat-soluble vitamin that
helps the body absorb calcium and
phosphorous for strong healthy bones.
Research shows that nearly one third
of the Australian population aged over
25 years has a Vitamin D deficiency,
even during summer and spring months.
According to Key Pharmaceuticals,
the availability of Ostevit-D one-a -week
as a Pharmacist-Only product will help
Australians comply with advice from
primary healthcare professionals for
Vitamin D deficiency. Meta-analysis has
demonstrated that once weekly dosing
regimens have the potential to improve
medication adherence compared to
Community pharmacist Nick Logan,
from Nick Logan Pharmacist Advice in
Sydney, says the new scheduling for
once weekly Vitamin D is a major win for
Australian consumers affected by Vitamin
‘Some people assume that Australia
must have low rates of Vitamin D
deficiency because of our climate and
ample sunlight. The reality is that we
have great need for a form of Vitamin D
that can deliver an effective solution to
deficiency while creating the opportunity
to improve adherence to therapy,’
Mr Logan said.
‘I think this new one-a -week option
will provide an important alternative
for the future now that it is available
over-the-counter. It will also help to
resolve compliance issues that we often
see with once-daily options.’
According to Mr Logan, the availability
of a one-a -week Vitamin D product
via the pharmacy will improve
accessibility to a more convenient
Vitamin D while also expanding the
community pharmacist’s consulting role
Ostevit-D one-a -week Vitamin D contains
7000 IU per capsule of cholecalciferol.
The product contains 30 capsules,
equivalent to a seven month supply.
* Note, this is based on a meta-analysis conducted
in a relevant patient population, but was not
specific for vitamin D
Links Archive Australian Pharmacist November 2015 Australian Pharmacist January 2016 Navigation Previous Page Next Page